Risk of Dilution in Per-Share Value from the Exercise of Stock Acquisition Rights
First written in FY2021. 6 of 12 entries say "Materialised", first in FY2022-Q2. Latest entry: FY2026.
Creema moved to the "Worse" side of this theme in 2021, the same year as the typical company in this theme.
The whole theme swung hardest in 2017: 28 of 54 companies on the "Worse" side.
52 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「At the end of the fiscal year, potential shares from stock acquisition rights totaled 291,000, equivalent to 4.32% of the 6,742,100 shares outstanding.」
Potential shares declined from 304,000, or 4.5%, in the previous fiscal year to 291,000, or 4.32%. - FY2025MitigatedAnnual report
「At the end of the fiscal year, potential shares from stock acquisition rights totaled 304,000, equivalent to 4.5% of the 6,740,100 shares outstanding.」
Potential shares declined from 345,000, or 5.1%, in the previous fiscal year to 304,000, or 4.5%. - FY2025-H1RestatedAnnual report
「(Note) Increase due to exercise of stock acquisition rights.」
The company states that the 2,000-share increase in total shares outstanding during the interim consolidated accounting period resulted from the exercise of stock acquisition rights. - FY2025-Q1MaterialisedAnnual report
「(Note) Increase due to exercise of stock acquisition rights.」
Between March and May 2024, the number of shares outstanding increased by 2,000 shares through the exercise of stock acquisition rights, meaning that part of the potential dilution materialized as an actual share issuance. - FY2024MitigatedAnnual report
「At the end of the fiscal year, potential shares from stock acquisition rights totaled 345,000, equivalent to 5.1% of the 6,733,100 shares outstanding.」
Potential shares totaled 345,000, or 5.1% of shares outstanding, down from 391,000 shares and 5.8% in the previous fiscal year. Meanwhile, 12,000 shares were issued during the year through the exercise of stock acquisition rights. - FY2024-Q3MaterialisedAnnual report
「(Note) Increase due to exercise of stock acquisition rights.」
Between September and November 2023, the number of shares outstanding increased by 1,000 shares through the exercise of stock acquisition rights, meaning that part of the potential dilution materialized as an actual share issuance. - FY2024-Q2MaterialisedAnnual report
「(Note) Increase due to exercise of stock acquisition rights.」
Between June and August 2023, the number of shares outstanding increased by 10,000 shares through the exercise of stock acquisition rights, meaning that part of the potential dilution materialized as an actual share issuance. - FY2024-Q1MaterialisedAnnual report
「(Note) Increase due to exercise of stock acquisition rights.」
Between March and May 2023, the number of shares outstanding increased by 1,000 shares through the exercise of stock acquisition rights, meaning that part of the potential dilution materialized as an actual share issuance. - FY2023MitigatedAnnual report
「At the end of the fiscal year, potential shares from stock acquisition rights totaled 391,000, equivalent to 5.8% of the 6,721,100 shares outstanding.」
Potential shares totaled 391,000, or 5.8% of shares outstanding, down from 464,000 shares and 7.0% in FY2021. During the year, 29,000 shares were also issued through the exercise of stock acquisition rights. - FY2023-Q2MaterialisedAnnual report
「(Note) Increase due to exercise of stock acquisition rights.」
Between 1 June and 31 August 2022, the number of shares outstanding increased by 28,000 shares through the exercise of stock acquisition rights, meaning that part of the potential dilution materialized as an actual share issuance. - FY2022-Q2MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
During the second quarter, the number of shares outstanding increased by 31,000 shares through the exercise of stock acquisition rights, meaning that part of the potential dilution materialized as an actual share issuance. - FY2021First statedAnnual report
「At the end of the fiscal year, potential shares from stock acquisition rights totaled 464,000 shares, equivalent to 7.0% of the 6,661,100 issued shares.」
The Company disclosed 464,000 potential shares, or 7.0% of issued shares, indicating the potential dilution from exercising stock acquisition rights.